Daewon Pharmaceutical Co., Ltd. (003220.KS) KSC
8,220.00
-120(-1.44%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
8,220.00
-120(-1.44%)
Currency In KRW
| Market Cap | 256.29B |
| Enterprise Value | 396.18B |
| P/E Ratio | -40.22 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 0.29 |
| Price/Book Ratio | 0.67 |
| Enterprise/Revenue | 0.55 |
| Enterprise/EBITDA | -7.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.01 |
| Operating Margin | -0 |
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
| Revenue | 605.64B |
| Revenue/Share | 28,267.76 |
| Gross Profit | 266.09B |
| EBITDA | 27.23B |
| Net Income | -1.38B |
| Diluted EPS | -64.37 |
| Total Cash | 56.01B |
| Total Cash/Share | 2,613.14 |
| Total Debt | 185.21B |
| Total Debt/Equity | 0.7 |
| Current Ratio | 1.18 |
| Book Value Per Share | 12,822.39 |
| 52-Week Change | -40.22 |
| 52-Week High | 14,700 |
| 52-Week Low | 8,070 |
| Moving Average 50 Days | 10,134.8 |
| Moving Average 200 Days | 11,790.65 |
| Average Volume | 35,761 |
| Shares Outstanding | 21.43M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 250 |
| Trailing Annual Dividend Yield | 3.04 |
| Payout Ratio | -1.47 |
| Last Split Factor | 103:100 |
| Last Split Date | March 07, 2022 |